by GlobeNewsWire | Sep 14, 2016 | Globe Newswire
SAN DIEGO, Sept. 14, 2016 (GLOBE NEWSWIRE) — Retrophin, Inc. (Nasdaq:RTRX) today announced that Alvin Shih, M.D., executive vice president and head of research & development, will present at the Leerink Partners Rare Disease & Immuno-Oncology Roundtable...
by GlobeNewsWire | Sep 14, 2016 | Globe Newswire
CAMBRIDGE, Mass., Sept. 14, 2016 (GLOBE NEWSWIRE) — Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by dysfunctional protein processing such as cystic fibrosis, today...
by GlobeNewsWire | Sep 14, 2016 | Globe Newswire
SOUTH SAN FRANCISCO, Calif., Sept. 14, 2016 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT), a biopharmaceutical company developing novel therapeutics for the treatment of grievous blood-based disorders with significant unmet need, today...
by GlobeNewsWire | Sep 14, 2016 | Globe Newswire
ROCKVILLE, Md., Sept. 14, 2016 (GLOBE NEWSWIRE) — Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN) today announced it has entered into a definitive agreement with institutional investors to purchase 24 million shares of its common stock and warrants exercisable for...
by GlobeNewsWire | Sep 14, 2016 | Globe Newswire
RALEIGH, N.C., Sept. 14, 2016 (GLOBE NEWSWIRE) — INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, together with the Center for Information and Study on Clinical Research Participation (CISCRP), a...